- Home
- Publications
- Publication Search
- Publication Details
Title
Splice-switching antisense oligonucleotides as therapeutic drugs
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 44, Issue 14, Pages 6549-6563
Publisher
Oxford University Press (OUP)
Online
2016-06-11
DOI
10.1093/nar/gkw533
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
- (2016) A. J. Hinrich et al. EMBO Molecular Medicine
- In vitroandin vivorescue of aberrant splicing inCEP290-associated LCA by antisense oligonucleotide delivery
- (2016) Alejandro Garanto et al. HUMAN MOLECULAR GENETICS
- Defective control of pre–messenger RNA splicing in human disease
- (2016) Benoit Chabot et al. JOURNAL OF CELL BIOLOGY
- Intrathecal Injections in Children With Spinal Muscular Atrophy
- (2016) Manon Haché et al. JOURNAL OF CHILD NEUROLOGY
- Modulation of LMNA splicing as a strategy to treat prelamin A diseases
- (2016) John M. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application
- (2016) Bastian Salewsky et al. MOLECULAR THERAPY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- The 3.8 A structure of the U4/U6.U5 tri-snRNP: Insights into spliceosome assembly and catalysis
- (2016) R. Wan et al. SCIENCE
- The Spliceosome: The Ultimate RNA Chaperone and Sculptor
- (2016) Panagiotis Papasaikas et al. TRENDS IN BIOCHEMICAL SCIENCES
- Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
- (2016) Gang Han et al. Nature Communications
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Antisense oligonucleotides in therapy for neurodegenerative disorders
- (2015) Melvin M. Evers et al. ADVANCED DRUG DELIVERY REVIEWS
- The Clothes Make the mRNA: Past and Present Trends in mRNP Fashion
- (2015) Guramrit Singh et al. Annual Review of Biochemistry
- Mechanisms and Regulation of Alternative Pre-mRNA Splicing
- (2015) Yeon Lee et al. Annual Review of Biochemistry
- Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project
- (2015) Jessica L. Larson et al. BMC Medical Genetics
- An update on RNA-targeting therapies for neuromuscular disorders
- (2015) Silvana Jirka et al. CURRENT OPINION IN NEUROLOGY
- An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies
- (2015) Graham McClorey et al. CURRENT OPINION IN PHARMACOLOGY
- Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy
- (2015) M. Gramlich et al. EMBO Molecular Medicine
- Gene and splicing therapies for neuromuscular diseases
- (2015) Aurelie Goyenvalle Frontiers in Bioscience-Landmark
- Oligonucleotide therapeutics: chemistry, delivery and clinical progress
- (2015) Vivek K Sharma et al. Future Medicinal Chemistry
- Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models
- (2015) Yimin Hua et al. GENES & DEVELOPMENT
- Gene-targeting pharmaceuticals for single-gene disorders
- (2015) Arthur L. Beaudet et al. HUMAN MOLECULAR GENETICS
- Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth
- (2015) Michael Dewaele et al. JOURNAL OF CLINICAL INVESTIGATION
- Disease Mechanisms and Therapeutic Approaches in Spinal Muscular Atrophy
- (2015) S. Tisdale et al. JOURNAL OF NEUROSCIENCE
- Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice
- (2015) Ngoc B Lu-Nguyen et al. MOLECULAR THERAPY
- Spinal Muscular Atrophy
- (2015) Stephen J. Kolb et al. NEUROLOGIC CLINICS
- Challenges of clinical trial design for DMD
- (2015) Valeria Ricotti et al. NEUROMUSCULAR DISORDERS
- Prevalence of Duchenne and Becker Muscular Dystrophies in the United States
- (2015) P. A. Romitti et al. PEDIATRICS
- Structural basis of pre-mRNA splicing
- (2015) Jing Hang et al. SCIENCE
- An alternative splicing event amplifies evolutionary differences between vertebrates
- (2015) S. Gueroussov et al. SCIENCE
- A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)
- (2015) Human Gene Therapy Clinical Development
- Dose-Dependent Pharmacokinetic Profiles of 2′-O-Methyl Phosphorothioate Antisense Oligonucleotidesin mdx Mice
- (2015) Ingrid E.C. Verhaart et al. Nucleic Acid Therapeutics
- Deep learning of the tissue-regulated splicing code
- (2014) Michael K. K. Leung et al. BIOINFORMATICS
- Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice
- (2014) B Wu et al. GENE THERAPY
- Development of Therapeutic Splice-Switching Oligonucleotides
- (2014) Petra Disterer et al. HUMAN GENE THERAPY
- Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models
- (2014) Erkan Y. Osman et al. HUMAN MOLECULAR GENETICS
- Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model
- (2014) Burcu Bestas et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
- (2014) Thomas Voit et al. LANCET NEUROLOGY
- Bubble Liposomes and Ultrasound Exposure Improve Localized Morpholino Oligomer Delivery into the Skeletal Muscles of Dystrophic mdx Mice
- (2014) Yoichi Negishi et al. MOLECULAR PHARMACEUTICS
- Observational study of spinal muscular atrophy type I and implications for clinical trials
- (2014) R. S. Finkel et al. NEUROLOGY
- Intrathecal delivery of protein therapeutics to the brain: A critical reassessment
- (2014) Pericles Calias et al. PHARMACOLOGY & THERAPEUTICS
- The human splicing code reveals new insights into the genetic determinants of disease
- (2014) H. Y. Xiong et al. SCIENCE
- Induced IL-10 Splice Altering Approach to Antiviral Drug Discovery
- (2014) Rekha G. Panchal et al. Nucleic Acid Therapeutics
- Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases
- (2014) Kavitha Siva et al. Nucleic Acid Therapeutics
- Skipping Multiple Exons of Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
- (2014) Yusuke Echigoya et al. Nucleic Acid Therapeutics
- Preventing Formation of Toxic N-Terminal Huntingtin Fragments Through Antisense Oligonucleotide-Mediated Protein Modification
- (2014) Melvin M. Evers et al. Nucleic Acid Therapeutics
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
- (2014) Fritz Eckstein Nucleic Acid Therapeutics
- Alternative Splice Forms of CTLA-4 Induced by Antisense Mediated Splice-Switching Influences Autoimmune Diabetes Susceptibility in NOD Mice
- (2014) Dan V. Mourich et al. Nucleic Acid Therapeutics
- Exon identity crisis: disease-causing mutations that disrupt the splicing code
- (2014) Timothy Sterne-Weiler et al. GENOME BIOLOGY
- What Can We Learn From Clinical Trials of Exon Skipping for DMD?
- (2014) Qi-long Lu et al. Molecular Therapy-Nucleic Acids
- A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy
- (2014) Jeffrey M Keil et al. Molecular Therapy-Nucleic Acids
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo
- (2013) T O Nielsen et al. BRITISH JOURNAL OF CANCER
- Rescue of cardiomyopathy through U7snRNA-mediated exon skipping inMybpc3-targeted knock-in mice
- (2013) Christina Gedicke-Hornung et al. EMBO Molecular Medicine
- Pathological impact ofSMN2mis-splicing in adult SMA mice
- (2013) Kentaro Sahashi et al. EMBO Molecular Medicine
- A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice
- (2013) Haiyan Zhou et al. HUMAN GENE THERAPY
- Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy
- (2013) Taeyoung Koo et al. HUMAN GENE THERAPY
- Exon Skipping of Hepatic APOB Pre-mRNA With Splice-switching Oligonucleotides Reduces LDL Cholesterol In Vivo
- (2013) Petra Disterer et al. MOLECULAR THERAPY
- Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. MUSCLE & NERVE
- Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness
- (2013) Jennifer J Lentz et al. NATURE MEDICINE
- Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon
- (2013) Melvin M. Evers et al. NEUROBIOLOGY OF DISEASE
- 195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14–16th December, 2012, Naarden, The Netherlands
- (2013) Juliet A. Ellis et al. NEUROMUSCULAR DISORDERS
- Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy
- (2013) Chalermchai Mitrpant et al. PLoS One
- Characterization of Target mRNA Reduction Through In Situ RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in Animals
- (2013) Gene Hung et al. Nucleic Acid Therapeutics
- Ultrasound-enhanced delivery of Morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice
- (2013) Michinori Koebis et al. Scientific Reports
- Targeting RNA splicing for disease therapy
- (2013) Mallory A. Havens et al. Wiley Interdisciplinary Reviews-RNA
- Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)
- (2013) A Seda Yılmaz-Eliş et al. Molecular Therapy-Nucleic Acids
- Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges
- (2012) Virginia Arechavala-Gomeza et al. CURRENT GENE THERAPY
- Use of Cell-Penetrating-Peptides in Oligonucleotide Splice Switching Therapy
- (2012) Samir A. El Andaloussi et al. CURRENT GENE THERAPY
- Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR)
- (2012) Hironori Uehara et al. FASEB JOURNAL
- Pathophysiological Insights Derived by Natural History and Motor Function of Spinal Muscular Atrophy
- (2012) Michelle A. Farrar et al. JOURNAL OF PEDIATRICS
- Childhood spinal muscular atrophy: controversies and challenges
- (2012) Eugenio Mercuri et al. LANCET NEUROLOGY
- Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing
- (2012) Eleanor Peacey et al. NUCLEIC ACIDS RESEARCH
- Morpholino-Mediated Increase in Soluble Flt-1 Expression Results in Decreased Ocular and Tumor Neovascularization
- (2012) Leah A. Owen et al. PLoS One
- Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery
- (2012) Y. Aoki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Evolutionary Landscape of Alternative Splicing in Vertebrate Species
- (2012) N. L. Barbosa-Morais et al. SCIENCE
- Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases
- (2012) Amber L. Southwell et al. TRENDS IN MOLECULAR MEDICINE
- Long-term Exon Skipping Studies With 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models
- (2012) Christa L Tanganyika-de Winter et al. Molecular Therapy-Nucleic Acids
- Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
- (2012) Corinne Betts et al. Molecular Therapy-Nucleic Acids
- Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals
- (2011) Meghan A. Campbell et al. CHEMICAL SOCIETY REVIEWS
- More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation
- (2011) Reini F Luco et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens
- (2011) Elaine A Sugarman et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
- (2011) Paul N. Porensky et al. HUMAN MOLECULAR GENETICS
- Chemical and Mechanistic Toxicology Evaluation of Exon Skipping Phosphorodiamidate Morpholino Oligomers in mdx Mice
- (2011) Peter Sazani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Repeat-Dose Toxicology Evaluation in Cynomolgus Monkeys of AVI-4658, a Phosphorodiamidate Morpholino Oligomer (PMO) Drug for the Treatment of Duchenne Muscular Dystrophy
- (2011) Peter Sazani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Induction of Antagonistic Soluble Decoy Receptor Tyrosine Kinases by Intronic PolyA Activation
- (2011) Sandra Vorlová et al. MOLECULAR CELL
- Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
- (2011) Mariko Taniguchi-Ikeda et al. NATURE
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
- (2011) Erich Koller et al. NUCLEIC ACIDS RESEARCH
- Antitumorigenic potential of STAT3 alternative splicing modulation
- (2011) F. Zammarchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging
- (2011) F. G. Osorio et al. Science Translational Medicine
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Newborn and carrier screening for spinal muscular atrophy
- (2010) Thomas W. Prior et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
- (2010) Hong M. Moulton et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity
- (2010) S. Cho et al. GENES & DEVELOPMENT
- Safety Pharmacology and Genotoxicity Evaluation of AVI-4658
- (2010) Peter Sazani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Antisense-induced Myostatin Exon Skipping Leads to Muscle Hypertrophy in Mice Following Octa guanidine Morpholino Oligomer Treatment
- (2010) Jagjeet K Kang et al. MOLECULAR THERAPY
- Deciphering the splicing code
- (2010) Yoseph Barash et al. NATURE
- Anti-tumor activity of splice-switching oligonucleotides
- (2010) John A. Bauman et al. NUCLEIC ACIDS RESEARCH
- A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy
- (2010) Natalia N. Singh et al. RNA Biology
- Spliceosome Structure and Function
- (2010) C. L. Will et al. Cold Spring Harbor Perspectives in Biology
- Efficacy of systemic morpholino exon-skipping in duchenne dystrophy dogs
- (2009) Toshifumi Yokota et al. ANNALS OF NEUROLOGY
- Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling
- (2009) S Rudnik-Schöneborn et al. CLINICAL GENETICS
- Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation
- (2009) D. Merrick et al. Disease Models & Mechanisms
- Antisense oligonucleotide pharmacokinetics and metabolism
- (2009) Richard S Geary Expert Opinion on Drug Metabolism & Toxicology
- In vivocomparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
- (2009) Hans A. Heemskerk et al. JOURNAL OF GENE MEDICINE
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Gene Knockdowns in Adult Animals: PPMOs and Vivo-Morpholinos
- (2009) Jon Moulton et al. MOLECULES
- RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice
- (2009) S. Svasti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
- (2008) Yimin Hua et al. AMERICAN JOURNAL OF HUMAN GENETICS
- An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models
- (2008) Maria A Graziewicz et al. MOLECULAR THERAPY
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
- Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
- (2008) Z. Wang et al. RNA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now